SCHEMBL2461606

SCHEMBL2461606

Cc1cc(/C=N\O)ccc1C(=O)NCC(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 3/20 0.36
LOXL2 Q9Y4K0 1/20 0.35
ESRRB O95718 1/20 0.35
ESRRG P62508 1/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
POLB P06746 2/20 0.34
TP53 P04637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PAX8 Q06710 1/20 0.34
KLF5 Q13887 1/20 0.34
HIF1A Q16665 1/20 0.34
MAPT P10636 1/20 0.34
LMNA P02545 2/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL737909 1.00 MAPK14 (0.40) MAPK14SMN1; SMN2HTTKMT2ALOXL2
SCHEMBL28416842 0.92 LMNA (0.40) MAPK14SMN1; SMN2HTTKMT2ANPC1
SCHEMBL28416839 0.92 LMNA (0.40) MAPK14SMN1; SMN2HTTKMT2ANPC1
SCHEMBL738418 0.85 MAPK14 (0.42) MAPK14SMN1; SMN2HTTLOXL2ESRRB
SCHEMBL2458608 0.80 KMT2A (0.50) MAPK14SMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL737425 0.80 KMT2A (0.50) MAPK14SMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL17666332 0.79 SMN1; SMN2 (0.57) MAPK14SMN1; SMN2HTTKMT2ANPC1
SCHEMBL23528835 0.77 LMNA (0.42) MAPK14SMN1; SMN2HTTKMT2ANPC1
SCHEMBL740695 0.76 MAPK14 (0.42) MAPK14SMN1; SMN2HTTLOXL2ESRRB
SCHEMBL738427 0.76 FLT1 (0.46) MAPK14SMN1; SMN2HTTKMT2ALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150105398-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2015-04-16 US disclosed
US-20130296559-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2013-11-07 US disclosed
US-8492311-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-07-23 US disclosed
US-20120172615-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed
US-20110251398-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-13 US disclosed
US-8022089-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-09-20 US disclosed
US-7662972-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-02-16 US disclosed
US-20090312330-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-12-17 US disclosed
US-20070066617-A1 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105398-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE C3AR1, C5, C9 MAPK14 2686/4885SMN1; SMN2 3838/4885HTT 2790/4885
US-20120172615-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE C3AR1, C5, C9 MAPK14 2701/4885SMN1; SMN2 4200/4885HTT 2158/4885
US-20090312330-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE ATM, CHRM1, NAT1 MAPK14 1530/4885SMN1; SMN2 2631/4885HTT 2030/4885
US-20130296559-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE C5, C3AR1, C9 MAPK14 2571/4885SMN1; SMN2 3786/4885HTT 2803/4885
US-20110251398-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE CBR3, CHRM1, CBR1 MAPK14 2151/4885SMN1; SMN2 1722/4885HTT 2613/4885
US-20070066617-A1 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly CHRM1, DDT, ATM MAPK14 1966/4885SMN1; SMN2 1906/4885HTT 2207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.